Updates matching "National"

Today, the U.S. House Committee on Ways and Means is expected to mark up the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R. 842).

As the September 30th government funding deadline nears, more than 700 cancer patients, survivors and advocates from every corner of the United States, including Washington, D.C., Guam, and Puerto Rico, are heading to Capitol Hill to make their voices heard. They will ask lawmakers to prioritize cancer research and prevention programs, along with other proven cancer-fighting policies, highlighting the real-life impact these investments have on patients, families and communities nationwide.

Tomorrow, the House Appropriations Committee is scheduled to consider the draft FY26 appropriations bill approved on September 2 nd by the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies. The bill includes an increase in funding for cancer research and cancer prevention and control programs.

More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.

A new ACS CAN study released in the Journal of the American Medical Association (JAMA) finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs and can improve the effectiveness of treatment and reduce the risk of adverse drug reactions.

Today, the U.S. Senate Committee on Appropriations considered and approved its draft FY26 appropriations bill that includes increases for the National Institutes of Health (NIH) and increases for federal cancer research funding at the National Cancer Institute (NCI).

Today, the U.S. Senate voted to confirm Susan Monarez, PhD, as the next Director of the Centers for Disease Control and Prevention (CDC).

A new report from the nonpartisan Congressional Budget Office (CBO) finds that proposed cuts at the National Institutes of Health (NIH) could lower the number of new drugs that come to market in the next three decades.

Following U.S. House passage of the budget bill containing the most devastating cuts to Medicaid in history and changes to the ACA Marketplace that will make it more expensive and difficult to obtain and keep health insurance, ACS CAN expresses deep disappointment and urges Congress to extend the enhanced ACA tax credits.